NAV
$38.38
AUM
$1.5B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +12.67% | +4.97% | +10.90% | +21.01% | +17.62% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.61% |
| 2 | AZN.L | AstraZeneca PLC | 2.39% |
| 3 | 6723.T | Renesas Electronics Corp | 2.11% |
| 4 | RR.L | Rolls-Royce Holdings PLC | 1.72% |
| 5 | UCG.MI | UniCredit SpA | 1.68% |
| 6 | SIE.DE | Siemens AG | 1.37% |
| 7 | ULVR.L | Unilever PLC | 1.37% |
| 8 | 005930.KS | Samsung Electronics Co Ltd | 1.32% |
| 9 | TTE.PA | TotalEnergies SE | 1.31% |
The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in equity securities. The fund normally invests at least 65% of its net assets (including any borrowings for investment purposes) in non-U.S. stocks. The fund will primarily invest in developed markets.
Inception Date: 2023-06-14